Skip to main content
. Author manuscript; available in PMC: 2009 Apr 21.
Published in final edited form as: J Infect Dis. 2008 Feb 15;197(4):544–547. doi: 10.1086/526793

Figure 1.

Figure 1

Bone marrow mononuclear cell (BMC) treatment of chronically infected mice. Shown are magnetic resonance images of an uninfected control mouse (A), an untreated chronically infected mouse (B), and a chronically infected mouse after BMC treatment (C) (note the enlarged right ventricle [RV] in panel B and the regression in panel C; white arrows and lines indicate the RV) as well as a graph (D) of the RV inner dimension (RVID) in control mice, untreated chronically infected mice (6 months after infection [MAI]), and chronically infected mice treated with BMCs for 1 (BMC-1M) through 4 (BMC-4M) months. Graphical data are presented as mean ± SE values. *P < .05 (statistically significant difference) for the comparison between the indicated groups.